Search research articles
Contact Us
Filters
Showing results (91-100 of 107) with videos related to
Page
of 11
Sort By:
Plos One
|
March 20, 2012
Delayed mTOR inhibition with low dose of everolimus reduces TGFβ expression, attenuates proteinuria and renal damage in the renal mass reduction model
Melania Kurdián, Inmaculada Herrero-Fresneda, Nuria Lloberas, et al.
Kidney International
|
June 21, 2013
Prospective assessment of antidonor cellular alloreactivity is a tool for guidance of immunosuppression in kidney transplantation
Oriol Bestard, Josep M Cruzado, Marc Lucia, et al.
Kidney International
|
June 30, 2023
A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction
Nuria Lloberas, Josep M Grinyó, Helena Colom, et al.
Atencion Primaria
|
July 3, 2026
Trough-to-peak ratios and elimination half-lives of antihypertensive drugs: implications for 24-hour blood pressure control in primary care
Mar Serrat-Costa, Gabriel Coll de Tuero, Ernest Vinyoles Bargalló, et al.
Pharmaceutics
|
May 27, 2023
The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations
Pere Fontova, Lisanne N van Merendonk, Anna Vidal-Alabró, et al.
Clinical Pharmacology and Therapeutics
|
February 24, 2021
Sustained Inhibition of Calcineurin Activity With a Melt-Dose Once-daily Tacrolimus Formulation in Renal Transplant Recipients
Pere Fontova, Helena Colom, Raül Rigo-Bonnin, et al.
Therapeutic Drug Monitoring
|
December 8, 2025
Tacrolimus Conversion in CYP3A5*1 Expressers: From Immediate-Release to LCP Formulation
Anna Vidal-Alabró, Pere Fontova, Zeyar Mohammed Ali, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 21, 2020
Cellular Immunity to Predict the Risk of Cytomegalovirus Infection in Kidney Transplantation: A Prospective, Interventional, Multicenter Clinical Trial
Marta Jarque, Elena Crespo, Edoardo Melilli, et al.
Kidney International Reports
|
October 26, 2020
A Comprehensive Phenotypic and Functional Immune Analysis Unravels Circulating Anti-Phospholipase A2 Receptor Antibody Secreting Cells in Membranous Nephropathy Patients
Chiara Cantarelli, Marta Jarque, Andrea Angeletti, et al.
Kidney & Blood Pressure Research
|
March 21, 2018
Fabry Nephropathy: An Evidence-Based Narrative Review
María Del Pino, Amado Andrés, Ana Ávila Bernabéu, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 107) with videos related to
Sort By:
Page
of 11
Plos One
|
March 20, 2012
Delayed mTOR inhibition with low dose of everolimus reduces TGFβ expression, attenuates proteinuria and renal damage in the renal mass reduction model
Melania Kurdián, Inmaculada Herrero-Fresneda, Nuria Lloberas, et al.
Kidney International
|
June 21, 2013
Prospective assessment of antidonor cellular alloreactivity is a tool for guidance of immunosuppression in kidney transplantation
Oriol Bestard, Josep M Cruzado, Marc Lucia, et al.
Kidney International
|
June 30, 2023
A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction
Nuria Lloberas, Josep M Grinyó, Helena Colom, et al.
Atencion Primaria
|
July 3, 2026
Trough-to-peak ratios and elimination half-lives of antihypertensive drugs: implications for 24-hour blood pressure control in primary care
Mar Serrat-Costa, Gabriel Coll de Tuero, Ernest Vinyoles Bargalló, et al.
Pharmaceutics
|
May 27, 2023
The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations
Pere Fontova, Lisanne N van Merendonk, Anna Vidal-Alabró, et al.
Clinical Pharmacology and Therapeutics
|
February 24, 2021
Sustained Inhibition of Calcineurin Activity With a Melt-Dose Once-daily Tacrolimus Formulation in Renal Transplant Recipients
Pere Fontova, Helena Colom, Raül Rigo-Bonnin, et al.
Therapeutic Drug Monitoring
|
December 8, 2025
Tacrolimus Conversion in CYP3A5*1 Expressers: From Immediate-Release to LCP Formulation
Anna Vidal-Alabró, Pere Fontova, Zeyar Mohammed Ali, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 21, 2020
Cellular Immunity to Predict the Risk of Cytomegalovirus Infection in Kidney Transplantation: A Prospective, Interventional, Multicenter Clinical Trial
Marta Jarque, Elena Crespo, Edoardo Melilli, et al.
Kidney International Reports
|
October 26, 2020
A Comprehensive Phenotypic and Functional Immune Analysis Unravels Circulating Anti-Phospholipase A2 Receptor Antibody Secreting Cells in Membranous Nephropathy Patients
Chiara Cantarelli, Marta Jarque, Andrea Angeletti, et al.
Kidney & Blood Pressure Research
|
March 21, 2018
Fabry Nephropathy: An Evidence-Based Narrative Review
María Del Pino, Amado Andrés, Ana Ávila Bernabéu, et al.
Page
of 11